Cargando…

Timing and sequence of vaccination against COVID-19 and influenza

Detalles Bibliográficos
Autores principales:	Liu, Jing, Liu, Xiangting, Liu, Shulan, Zeng, Guangting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228257/ https://www.ncbi.nlm.nih.gov/pubmed/37274778 http://dx.doi.org/10.1016/j.lanepe.2023.100663

Ejemplares similares

Timing and sequence of vaccination against COVID-19 and influenza – Author's reply
por: Dulfer, Elisabeth A., et al.
Publicado: (2023)

Re: ‘efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis’ by Deng et al.
por: Zeng, Guangting, et al.
Publicado: (2023)

Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine
por: Zeng, Guangting
Publicado: (2022)

Cardiovascular Complications Are the Executioners of Inpatient With SARS-CoV-2 Community-Acquired Pneumonia
por: Zeng, Guangting
Publicado: (2023)

Association between Covid-19 Vaccination and Influenza Vaccination Rates
por: Leuchter, Richard K., et al.
Publicado: (2022)

Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection
por: Zeng, Guangting, et al.
Publicado: (2023)

Can influenza vaccine modify COVID-19 clinical course?
por: Eldanasory, Omar Abdelhay, et al.
Publicado: (2020)

Re: Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil by Ranzani et al.
por: Zeng, Guangting
Publicado: (2022)

Willingness to vaccinate against COVID-19 in Australia
por: Dodd, Rachael H, et al.
Publicado: (2021)

Intention to vaccinate against COVID-19 in Australia
por: Rhodes, Anthea, et al.
Publicado: (2021)

Influenza and Covid-19 in Children: Time to Have a Close Watch!
por: Kori, Aparna, et al.
Publicado: (2022)

Re: ‘Association between IgG antibody levels and adverse events after first and second BNT162b2 mRNA vaccine doses’ by Braun et al
por: Zhou, Yuchi, et al.
Publicado: (2022)

Comparison of laboratory data between children with COVID‐19 and influenza
por: Liu, Xiao‐Ping, et al.
Publicado: (2021)

Ecological fallacy in COVID-19 epidemiological inference: Influenza vaccination rate as an example
por: Chen, Yi-Chu, et al.
Publicado: (2021)

BCG Vaccination Protection Against COVID-19: Correspondence
por: Singh, Surjit, et al.
Publicado: (2021)

Global influenza surveillance in times of COVID-19: Robbing Peter to pay Paul?()
por: Sanz-Muñoz, I., et al.
Publicado: (2021)

Global COVID-19 vaccine roll-out: time to randomise vaccine allocation?
por: Watson, Samuel I, et al.
Publicado: (2021)

Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines Against COVID-19 Hospitalizations: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

BCG Vaccination Policy and Protection Against COVID-19: Correspondence
por: Mohapatra, Prasanta Raghab, et al.
Publicado: (2020)

Erythema nodosum, after Medigen vaccination against COVID-19?
por: Hsu, Hui-Te, et al.
Publicado: (2022)

WHO prequalified tocilizumab and vaccine boosters against COVID-19
por: Rahimi, Farid, et al.
Publicado: (2022)

Guillain-Barré syndrome after vaccination against COVID-19
por: Chun, June Young, et al.
Publicado: (2022)

Characterising adults in Scotland who are not vaccinated against COVID-19
por: Hameed, Safraj Shahul, et al.
Publicado: (2022)

Next-generation sequencing revealed influenza and Chlamydia infection in recurrent pneumonia in a patient who had recovered from COVID-19
por: Wen, Wen, et al.
Publicado: (2020)

Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19
por: Lim, Wey Wen, et al.
Publicado: (2021)

Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant
por: Higdon, Melissa M, et al.
Publicado: (2022)

The impact of anti-epidemic measures against coronavirus disease 2019 (COVID-19) on the seasonal influenza epidemic
por: Ilyicheva, Tatyana N., et al.
Publicado: (2021)

Influenza vaccination coverage in Japan
por: Lee, Jung Su, et al.
Publicado: (2003)

Vaccine efficacy against COVID-19: A foresight on the host-associated factors
por: Priyanka, et al.
Publicado: (2021)

Influenza control during the COVID-19 pandemic
por: Hills, Thomas, et al.
Publicado: (2020)

Corneal Graft Rejection after Vaccination against COVID-19: A Case Report
por: Park, Ji Min, et al.
Publicado: (2023)

Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients
por: Solera, Javier T, et al.
Publicado: (2023)

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
por: Regev-Yochay, Gili, et al.
Publicado: (2022)

Cardiovascular Hospitalizations, Influenza Activity, and COVID-19 Measures
por: Myhre, Peder L., et al.
Publicado: (2020)

Covid-19 Vaccine Acceptance in California State Prisons
por: Chin, Elizabeth T., et al.
Publicado: (2021)

The effects of COVID-19 pandemic on the trend of measles and influenza in Europe
por: Gianfredi, Vincenza, et al.
Publicado: (2021)

Whether the timing of patient randomization interferes with the assessment of the efficacy of ruxolitinib for severe COVID-19
por: Li, Hailan, et al.
Publicado: (2020)

COVID-19 Vaccine Effectiveness
por: Shader, Richard I.
Publicado: (2021)

Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
por: Shaw, Robert H, et al.
Publicado: (2021)

Booster vaccines for COVID-19 vaccine breakthrough cases?
por: Nixon, Douglas F, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p59aa8gnjk3u7r241r9ai7s8rr